Sutent (sunitinib)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Sutent (sunitinib), covering 2024-09-19 to 2025-02-14. Get the full timeline:
Most recent: Clinical Trial Update: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy [Phase 3]